LGND Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.00%

Insider Buying (Last 12 Months): $1,400,017.00

Insider Selling (Last 12 Months): $6,708,246.79

Ligand Pharmaceuticals Insider Trading History Chart

Ligand Pharmaceuticals Share Price & Price History

^$121.70

▼ -3.28 (-2.62%)

As of 07/11/2025 05:00 PM ET

Days: 30 | 90 | 365

Ligand Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/10/2025	John W. Kozarich	Director	Sell	934	$125.00	$116,750.00	46,456
6/23/2025	Andrew Reardon	Insider	Sell	500	$114.08	$57,040.00	31,903
6/10/2025	Andrew Reardon	Insider	Sell	500	$114.54	$57,270.00	32,403
5/15/2025	Andrew Reardon	Insider	Sell	1,000	$104.00	$104,000.00	32,903
5/9/2025	Octavio Espinoza	CFO	Buy	1,500	$104.06	$156,090.00	27,932
5/9/2025	Todd C. Davis	CEO	Buy	9,510	$105.20	$1,000,452.00	161,234
3/4/2025	Octavio Espinoza	CFO	Sell	5,000	$115.03	$575,150.00	18,879
12/23/2024	Octavio Espinoza	CFO	Sell	2,104	$116.37	$244,842.48	20,647
11/27/2024	John L. LaMattina	Director	Sell	2,406	$123.65	$297,501.90	29,515
9/23/2024	Andrew Reardon	Insider	Sell	2,000	$99.60	$199,200.00	22,534
9/23/2024	Matthew E Korenberg	COO	Sell	9,772	$101.22	$989,121.84	50,777
9/20/2024	Matthew E Korenberg	COO	Sell	6,275	$104.10	$653,227.50	50,777
9/20/2024	Octavio Espinoza	CFO	Sell	1,275	$103.94	$132,523.50	24,610
8/28/2024	Andrew Reardon	Insider	Sell	1,500	$106.39	$159,585.00	22,534
8/26/2024	Matthew E Korenberg	COO	Sell	11,389	$105.61	$1,202,792.29	49,510
8/22/2024	Matthew E Korenberg	COO	Sell	1,157	$105.54	$122,109.78	67,211
8/9/2024	Matthew E Korenberg	COO	Sell	18,245	$98.50	$1,797,132.50	68,368
8/8/2024	Todd C. Davis	CEO	Buy	2,500	$97.39	$243,475.00	123,010
5/17/2024	Octavio Espinoza	CFO	Sell	5,156	$86.66	$446,818.96	23,379
5/15/2024	Octavio Espinoza	CFO	Sell	5,873	$86.01	$505,136.73	23,882
5/13/2024	Matthew E Korenberg	Insider	Sell	3,440	$84.54	$290,817.60	100,421
5/9/2024	Andrew Reardon	Insider	Sell	10,000	$83.04	$830,400.00	22,205
5/9/2024	Nancy Ryan Gray	Director	Sell	934	$83.20	$77,708.80	5,633
3/5/2024	Stephen L. Sabba	Director	Sell	1,893	$74.30	$140,649.90	28,926
2/28/2024	Octavio Espinoza	CFO	Sell	140	$88.46	$12,384.40	29,755
9/22/2023	Todd C. Davis	CEO	Buy	4,000	$59.38	$237,520.00	73,090
5/16/2023	John W. Kozarich	Director	Sell	4,444	$77.20	$343,076.80	38,488
5/10/2023	Stephen L. Sabba	Director	Sell	6,408	$77.13	$494,249.04	25,784
5/8/2023	John W. Kozarich	Director	Sell	6,408	$76.56	$490,596.48	42,213
3/24/2023	Andrew Reardon	Insider	Sell	300	$69.92	$20,976.00	16,308
12/16/2022	John L. Higgins	Director	Sell	10,000	$61.87	$618,700.00	422,984
11/17/2022	John L. Higgins	CEO	Sell	10,000	$78.32	$783,200.00	416,731
11/9/2022	Octavio Espinoza	CFO	Sell	1,696	$75.64	$128,285.44	8,857
9/15/2022	John L. Higgins	CEO	Sell	2,000	$90.00	$180,000.00	367,180

SEC Filings (Institutional Ownership Changes) for Ligand Pharmaceuticals (NASDAQ:LGND)

91.28% of Ligand Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Ligand Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
7/11/2025	BTC Capital Management Inc.	3,423	$0.39M	0.0%	+10.6%	0.018%
7/10/2025	CWC Advisors LLC.	3,518	$0.40M	0.2%	+2.6%	0.018%
7/10/2025	Contravisory Investment Management Inc.	2,261	$0.26M	0.1%	N/A	0.012%
7/9/2025	Woodstock Corp	29,497	$3.35M	0.3%	+0.3%	0.153%
6/18/2025	Voya Investment Management LLC	4,750	$0.50M	0.0%	-8.0%	0.025%
5/29/2025	Rhumbline Advisers	57,456	$6.04M	0.0%	-3.3%	0.298%
5/28/2025	Strs Ohio	7,500	$0.79M	0.0%	N/A	0.039%
5/28/2025	Ellsworth Advisors LLC	7,272	$0.77M	0.2%	N/A	0.038%
5/19/2025	Jane Street Group LLC	36,922	$3.88M	0.0%	+176.2%	0.191%
5/19/2025	UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC	55,327	$5.82M	0.0%	+9.8%	0.287%
5/16/2025	Goldman Sachs Group Inc.	84,855	$8.92M	0.0%	-23.3%	0.440%
5/16/2025	Uniplan Investment Counsel Inc.	68,792	$7.23M	0.7%	+0.9%	0.357%
5/16/2025	NFJ Investment Group LLC	12,917	$1.36M	0.0%	+9.0%	0.067%
5/16/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	10,660	$1.12M	0.0%	+8.2%	0.055%
5/16/2025	Jacobs Levy Equity Management Inc.	157,181	$16.53M	0.1%	N/A	0.815%
5/16/2025	Clark Capital Management Group Inc.	44,054	$4.63M	0.0%	+18.2%	0.228%
5/16/2025	AQR Capital Management LLC	3,335	$0.34M	0.0%	N/A	0.017%
5/16/2025	Advisors Asset Management Inc.	2,841	$0.30M	0.0%	+26.2%	0.015%
5/16/2025	Amundi	7,627	$0.79M	0.0%	-20.1%	0.040%
5/15/2025	Royal Bank of Canada	6,120	$0.64M	0.0%	+25.8%	0.032%
5/15/2025	Graham Capital Management L.P.	6,052	$0.64M	0.0%	+21.1%	0.031%
5/15/2025	Quarry LP	500	$53K	0.0%	-58.3%	0.003%
5/15/2025	Ashford Capital Management Inc.	298,035	$31.34M	4.0%	-4.1%	1.546%
5/15/2025	Baird Financial Group Inc.	11,637	$1.22M	0.0%	-84.9%	0.060%
5/15/2025	Driehaus Capital Management LLC	162,170	$17.05M	0.2%	-0.4%	0.841%
5/14/2025	Corebridge Financial Inc.	9,384	$0.99M	0.0%	+1.2%	0.049%
5/14/2025	Comerica Bank	7,376	$0.78M	0.0%	-2.8%	0.038%
5/14/2025	MetLife Investment Management LLC	10,292	$1.08M	0.0%	-1.8%	0.053%
5/14/2025	Penn Capital Management Company LLC	120,839	$12.72M	1.2%	+15.7%	0.627%
5/14/2025	CW Advisors LLC	96,314	$10.13M	0.1%	+2.1%	0.500%
5/14/2025	Martingale Asset Management L P	19,052	$2M	0.1%	+5.3%	0.099%
5/13/2025	Northern Trust Corp	293,808	$30.89M	0.0%	+3.8%	1.524%
5/13/2025	American Century Companies Inc.	40,456	$4.25M	0.0%	+8.6%	0.210%
5/13/2025	Aberdeen Group plc	216,241	$22.74M	0.0%	+22.3%	1.122%
5/13/2025	Cookson Peirce & Co. Inc.	8,915	$0.94M	0.0%	+16.5%	0.046%
5/13/2025	Russell Investments Group Ltd.	135,365	$14.23M	0.0%	+41.6%	0.702%
5/13/2025	HighTower Advisors LLC	5,300	$0.56M	0.0%	-4.4%	0.027%
5/12/2025	Public Sector Pension Investment Board	59,878	$6.30M	0.0%	+27.1%	0.311%
5/12/2025	Nuveen LLC	44,296	$4.66M	0.0%	N/A	0.230%
5/12/2025	Invesco Ltd.	202,828	$21.33M	0.0%	+4.4%	1.052%
5/12/2025	Connor Clark & Lunn Investment Management Ltd.	2,944	$0.31M	0.0%	-87.6%	0.015%
5/12/2025	Townsquare Capital LLC	36,774	$3.87M	0.0%	+6.5%	0.191%
5/12/2025	Swiss National Bank	36,600	$3.85M	0.0%	+1.7%	0.190%
5/12/2025	Maryland State Retirement & Pension System	5,519	$0.58M	0.0%	-13.3%	0.029%
5/9/2025	Mutual of America Capital Management LLC	2,752	$0.29M	0.0%	-3.8%	0.014%
5/9/2025	CenterBook Partners LP	68,299	$7.18M	0.5%	+190.2%	0.354%
5/9/2025	Deutsche Bank AG	287,965	$30.28M	0.0%	-0.4%	1.494%
5/9/2025	Charles Schwab Investment Management Inc.	168,874	$17.76M	0.0%	-0.9%	0.876%
5/9/2025	Vanguard Group Inc.	2,055,732	$216.14M	0.0%	-1.4%	10.662%
5/8/2025	US Bancorp DE	4,059	$0.43M	0.0%	+435.5%	0.021%
5/7/2025	Essex Investment Management Co. LLC	61,702	$6.49M	1.4%	-5.4%	0.320%
5/7/2025	Zurcher Kantonalbank Zurich Cantonalbank	2,516	$0.27M	0.0%	+4.9%	0.013%
5/7/2025	Equitable Trust Co.	4,535	$0.48M	0.0%	+20.0%	0.024%
5/6/2025	Pacer Advisors Inc.	2,519	$0.27M	0.0%	N/A	0.013%
5/6/2025	Burney Co.	14,861	$1.56M	0.1%	+9.9%	0.077%
5/6/2025	Legato Capital Management LLC	19,558	$2.06M	0.3%	+8.3%	0.101%
5/6/2025	Universal Beteiligungs und Servicegesellschaft mbH	21,086	$2.22M	0.0%	N/A	0.109%
5/5/2025	GW&K Investment Management LLC	34,858	$3.67M	0.0%	-0.9%	0.181%
5/5/2025	Jackson Creek Investment Advisors LLC	12,425	$1.31M	0.4%	-26.7%	0.064%
5/2/2025	Victory Capital Management Inc.	27,678	$2.91M	0.0%	+94.6%	0.144%
5/2/2025	Massachusetts Financial Services Co. MA	277,791	$29.21M	0.0%	+0.4%	1.441%
5/1/2025	Rice Hall James & Associates LLC	297,221	$31.25M	1.8%	-2.5%	1.542%
5/1/2025	Isthmus Partners LLC	37,675	$3.96M	0.5%	-1.1%	0.195%
5/1/2025	Louisiana State Employees Retirement System	8,900	$0.94M	0.0%	-2.2%	0.046%
5/1/2025	Stephens Investment Management Group LLC	607,222	$63.84M	0.9%	-0.9%	3.149%
5/1/2025	New York State Common Retirement Fund	99,537	$10.47M	0.0%	+7.7%	0.516%
5/1/2025	Mutual of America Capital Management LLC	2,752	$0.29M	0.0%	-3.8%	0.014%
5/1/2025	Arizona State Retirement System	5,407	$0.57M	0.0%	+2.1%	0.028%
4/30/2025	Court Place Advisors LLC	5,308	$0.56M	0.2%	-8.2%	0.028%
4/30/2025	China Universal Asset Management Co. Ltd.	3,862	$0.41M	0.0%	-3.6%	0.020%
4/29/2025	Envestnet Asset Management Inc.	26,608	$2.80M	0.0%	-69.5%	0.138%
4/29/2025	Bank of New York Mellon Corp	126,571	$13.31M	0.0%	-2.6%	0.656%
4/29/2025	Calamos Advisors LLC	19,934	$2.10M	0.0%	+38.3%	0.103%
4/28/2025	Principal Financial Group Inc.	102,874	$10.82M	0.0%	+3.3%	0.534%
4/28/2025	Oregon Public Employees Retirement Fund	4,342	$0.46M	0.0%	-2.3%	0.023%
4/28/2025	Teacher Retirement System of Texas	5,079	$0.53M	0.0%	-6.2%	0.026%
4/25/2025	Amalgamated Bank	5,360	$0.56M	0.0%	-3.0%	0.028%
4/25/2025	Lisanti Capital Growth LLC	52,575	$5.53M	1.6%	+34.8%	0.273%
4/24/2025	CWC Advisors LLC.	3,430	$0.36M	0.2%	+31.5%	0.018%
4/24/2025	Villere ST Denis J & Co. LLC	288,827	$30.37M	2.9%	+0.6%	1.500%
4/24/2025	Allspring Global Investments Holdings LLC	96,419	$10.14M	0.0%	-3.6%	0.501%
4/24/2025	Illinois Municipal Retirement Fund	10,725	$1.13M	0.0%	+9.2%	0.056%
4/22/2025	Advisor Resource Council	22,425	$2.24M	0.2%	N/A	0.116%
4/21/2025	Janney Capital Management LLC	4,169	$0.44M	0.0%	-8.7%	0.022%
4/21/2025	State of Alaska Department of Revenue	10,470	$1.10M	0.0%	-2.5%	0.054%
4/17/2025	Chicago Capital LLC	554,517	$58.30M	1.6%	+0.5%	2.880%
4/17/2025	Exchange Traded Concepts LLC	1,153	$0.12M	0.0%	+1,289.2%	0.006%
4/16/2025	Opal Wealth Advisors LLC	305	$32K	0.0%	N/A	0.002%
4/15/2025	Handelsbanken Fonder AB	6,658	$0.70M	0.0%	+13.7%	0.035%
4/15/2025	SG Americas Securities LLC	6,808	$0.72M	0.0%	+323.6%	0.035%
4/15/2025	GAMMA Investing LLC	593	$62K	0.0%	+68.5%	0.003%
4/14/2025	Yousif Capital Management LLC	7,012	$0.74M	0.0%	-2.5%	0.036%
4/14/2025	Farther Finance Advisors LLC	633	$66K	0.0%	-17.4%	0.003%
4/14/2025	Portside Wealth Group LLC	3,575	$0.38M	0.1%	+3.2%	0.019%
4/11/2025	Congress Asset Management Co.	642,712	$67.58M	0.5%	+3.4%	3.338%
4/10/2025	Portside Wealth Group LLC	3,463	$0.37M	0.1%	+12.3%	0.018%
4/8/2025	Rhumbline Advisers	57,456	$6.04M	0.0%	-3.3%	0.298%
4/8/2025	BTC Capital Management Inc.	3,096	$0.33M	0.0%	-6.3%	0.016%
4/7/2025	Summit Global Investments	10,825	$1.14M	0.1%	+145.0%	0.056%
4/7/2025	GAMMA Investing LLC	62,348	$6.56M	0.0%	+17,612.5%	0.324%

Data available starting January 2016

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, engages in the development and licensing of biopharmaceutical assets worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Rylaze, a recombinant erwinia asparaginase for the treatment of acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; Filspari, a dual endothelin and angiotensin II receptor antagonist in development for rare kidney diseases and non-immunosuppressive treatment indicated for immunoglobulin A nephropathy; Teriparatide injection product for osteoporosis; Vaxneuvance for the prevention of invasive disease caused by streptococcus pneumoniae serotypes; and Pneumosil, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia among children. The company also offers TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes (T1D) in adults and children aged 8 years and older with Stage 2 T1D; Nexterone, a captisol-enabled formulation of amiodarone; Zulresso, a captisol-enabled formulation of brexanolone for the treatment of postpartum depression; and Veklury, an antiviral treatment for moderate or severe COVID-19. In addition, it provides Noxafil-IV, a captisol-enabled formulation of posaconazole for IV use; Duavee for the treatment of post-menopausal symptoms in women; Exemptia for autoimmune diseases; Vivitra for breast cancer; and Bryxta and Zybev for various indications. The company has alliances, licenses, and other business relationships with Amgen, Merck, Pfizer, Jazz, Takeda, Gilead Sciences, and Baxter International. Further, it sells Captisol materials. Ligand Pharmaceuticals Incorporated was incorporated in 1987 and is based in Jupiter, Florida.

Today's Range

Now: $121.70

$120.74

$124.52

50 Day Range

MA: $109.40

$100.19

$124.98

52 Week Range

Now: $121.70

$90.29

$129.90

Volume

106,482 shs

Average Volume

116,807 shs

Market Capitalization

$2.35 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.84

Who are the company insiders with the largest holdings of Ligand Pharmaceuticals?: Ligand Pharmaceuticals' top insider investors include:
Todd C Davis (CEO)
Matthew E Korenberg (Insider)
Matthew E Korenberg (COO)
Andrew Reardon (Insider)
Octavio Espinoza (CFO)
John L Lamattina (Director)
Stephen L Sabba (Director)
Nancy Ryan Gray (Director)
Learn More about top insider investors at Ligand Pharmaceuticals.
Who are the major institutional investors of Ligand Pharmaceuticals?: Ligand Pharmaceuticals' top institutional investors include:
Woodstock Corp — 0.15%
CWC Advisors LLC. — 0.02%
Contravisory Investment Management Inc. — 0.01%
Learn More about top institutional investors of Ligand Pharmaceuticals stock.
Which institutional investors are buying Ligand Pharmaceuticals stock?: In the last quarter, LGND stock was acquired by institutional investors including:
Contravisory Investment Management Inc.
Woodstock Corp
CWC Advisors LLC.
During the last year, these company insiders have bought Ligand Pharmaceuticals stock:
Todd C Davis (CEO)
Matthew E Korenberg (Insider)
Learn More investors buying Ligand Pharmaceuticals stock.